What is the best pharmacological treatment to prevent exacerbation of chronic obstructive pulmonary disease?

Polskie Archiwum Medycyny Wewnetrznej

Volumn 118, Issue 4, 2008, Pages 172-174

  Celli, Bartolome R ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; PLACEBO; SALMETEROL; TIOTROPIUM BROMIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; EDITORIAL; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; LUNG FUNCTION; MONOTHERAPY; MORBIDITY; MORTALITY; QUALITY OF LIFE;

EID: 42949108815     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.348     Document Type: Editorial

References (11)